Author(s):
Gude Sai Sushmitha, Girish Pai, Muddu Krishna, S G Vasantharaju
Email(s):
sgvasanth65@gmail.com
DOI:
10.5958/0974-360X.2018.00875.2 
Address:
Gude Sai Sushmitha1, Dr. Girish Pai2, Dr. Muddu Krishna1, Dr. S G Vasantharaju1*
1Department of Pharmaceutical Quality Assurance, Manipal Academy of Higher Education,
Manipal- 576104, India.
2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal- 576 104, India.
*Corresponding Author
Published In:
Volume - 11,
Issue - 11,
Year - 2018
ABSTRACT:
Nabumetone is a Non-steroidal anti-inflammatory drug (NSAID) which belongs to a drug class which provide antipyretic and analgesic effects in lower doses and anti-inflammatory effects in higher doses.
Cite this article:
Gude Sai Sushmitha, Girish Pai, Muddu Krishna, S G Vasantharaju. Development of Multiple Time Point Stability Indicating Assay Method and Validation of Nabumetone by RP-HPLC. Research J. Pharm. and Tech 2018; 11(11): 4813-4820. doi: 10.5958/0974-360X.2018.00875.2
Cite(Electronic):
Gude Sai Sushmitha, Girish Pai, Muddu Krishna, S G Vasantharaju. Development of Multiple Time Point Stability Indicating Assay Method and Validation of Nabumetone by RP-HPLC. Research J. Pharm. and Tech 2018; 11(11): 4813-4820. doi: 10.5958/0974-360X.2018.00875.2 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2018-11-11-7